Now, BPC-157 is just not licensed for human use because it lacks acceptance for almost any indicator. The proper dosage to be used beyond laboratory environments remains undetermined. The advertising and marketing impact of pentadecapeptide BPC 157 on tendon therapeutic involves tendon outgrowth,